← Leaderboards
Barbara A Osborne
University Of Massachusetts Amherst
$7,857,536
Attributed
$8,679,824
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,523,017 · 14
By mechanism
P01$12,748,109 · 5
R01$3,646,354 · 3
R41$898,945 · 2
R21$423,847 · 1
R56$377,866 · 1
T32$263,098 · 1
Top collaborators
- Katherine L Knight3 shared
- Juan Anguita2 shared
- Jeanne Ann Hardy1 shared
- Shelly R. Peyton1 shared
- Susan Celia Roberts1 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIn VivoSignal TransductionNotch ProteinMediatingIn VitroDesignResearch StudyInhibitor/AntagonistGamma SecretaseT-LymphocyteImmune ResponseComplexResponseSecretaseInsightSignal PathwayGenerationsPlayEnzymesProgramsMalignant NeoplasmsCollaborationsProteins
Grant awards (50)
Dendritic cell therapy for GvHD$298,956
R41 · FY2025 · AI
Dendritic cell therapy for GvHD$299,989
R41 · FY2024 · AI
Prevention of GVHD by a probiotic exopolysaccharide.$300,000
R41 · FY2020 · AI
Targeting Multiple Diseases Through Gamma Secretase$951,325
P01 · FY2017 · CA · contact PI
Targeting y-secretase in GVHD$232,770
P01 · FY2017 · CA · contact PI
Administrative Core$31,423
P01 · FY2017 · CA · contact PI
Targeting Multiple Diseases Through Gamma Secretase$951,325
P01 · FY2016 · CA · contact PI
Targeting y-secretase in GVHD$232,770
P01 · FY2016 · CA · contact PI
Cellular Engineering Biotechnology Training Program$176,056
T32 · FY2016 · GM · contact PI
Targeting Multiple Diseases Through Gamma Secretase$63,788
P01 · FY2016 · CA · contact PI
Administrative Core$31,423
P01 · FY2016 · CA · contact PI
Targeting Multiple Diseases Through Gamma Secretase$951,325
P01 · FY2015 · CA · contact PI
Targeting y-secretase in GVHD$232,415
P01 · FY2015 · CA · contact PI
Cellular Engineering Biotechnology Training Program$87,042
T32 · FY2015 · GM · contact PI
Targeting Multiple Diseases Through Gamma Secretase$63,788
P01 · FY2015 · CA · contact PI
Administrative Core$31,069
P01 · FY2015 · CA · contact PI
Targeting Multiple Diseases Through Gamma Secretase$922,785
P01 · FY2014 · CA · contact PI
Targeting y-secretase in GVHD$225,787
P01 · FY2014 · CA · contact PI
Administrative Core$30,479
P01 · FY2014 · CA · contact PI
Targeting Multiple Diseases Through Gamma Secretase$980,825
P01 · FY2013 · CA · contact PI
Targeting y-secretase in GVHD$239,988
P01 · FY2013 · CA · contact PI
Administrative Core$32,398
P01 · FY2013 · CA · contact PI
Notch and TLRs Cross Paths in the Innate Immune System$52,589
R03 · FY2012 · TW · contact PI
Targeting Multiple Diseases Through Gamma Secretase$116,250
P01 · FY2011 · AG · contact PI
Notch and TLRs Cross Paths in the Innate Immune System$52,589
R03 · FY2011 · TW · contact PI
Targeting Multiple Diseases Through Gamma Secretase$954,099
P01 · FY2010 · AG · contact PI
The Role of Notch Signaling in Tcell Function$377,866
R56 · FY2010 · AI · contact PI
IN VIVO EFFECTS OY Y-SECRETASE INHIBITION IN THE IMMUNE SYSTEM$313,875
P01 · FY2010 · AG · contact PI
Regulation of Th17 Responses by y-secretase$231,452
R21 · FY2010 · AI · contact PI
Notch and TLRs Cross Paths in the Innate Immune System$59,620
R03 · FY2010 · TW · contact PI
Targeting Multiple Diseases Through Gamma Secretase$953,782
P01 · FY2009 · AG · contact PI
IN VIVO EFFECTS OY Y-SECRETASE INHIBITION IN THE IMMUNE SYSTEM$315,078
P01 · FY2009 · AG · contact PI
Regulation of Th17 Responses by y-secretase$192,395
R21 · FY2009 · AI · contact PI
Targeting Multiple Diseases Through Gamma Secretase$944,332
P01 · FY2008 · AG · contact PI
The role of Notch signaling in T cell function$321,684
R01 · FY2008 · AI · contact PI
IN VIVO EFFECTS OY Y-SECRETASE INHIBITION IN THE IMMUNE SYSTEM$313,313
P01 · FY2008 · AG · contact PI
Targeting Multiple Diseases Through Gamma Secretase$963,895
P01 · FY2007 · AG · contact PI
The role of Notch signaling in T cell function$327,914
R01 · FY2007 · AI · contact PI
IN VIVO EFFECTS OY Y-SECRETASE INHIBITION IN THE IMMUNE SYSTEM$321,330
P01 · FY2007 · AG · contact PI
Targeting Multiple Diseases Through Gamma Secretase$1,025,674
P01 · FY2006 · AG · contact PI
Polyclonal human antibody in cloned HAC-transgenic cows$375,544
R01 · FY2006 · AI · contact PI
The role of Notch signaling in T cell function$337,708
R01 · FY2006 · AI · contact PI
IN VIVO EFFECTS OY Y-SECRETASE INHIBITION IN THE IMMUNE SYSTEM$320,798
P01 · FY2006 · AG · contact PI
Polyclonal human antibody in cloned HAC-transgenic cows$384,582
R01 · FY2005 · AI
The role of Notch signaling in T cell function$345,835
R01 · FY2005 · AI
Polyclonal human antibody in cloned HAC-transgenic cows$384,582
R01 · FY2004 · AI
The role of Notch signaling in T cell function$345,835
R01 · FY2004 · AI
MOLECULAR ANALYSIS OF APOPTOSIS IN T CELLS$282,134
R01 · FY2002 · AG
MOLECULAR ANALYSIS OF APOPTOSIS IN T CELLS$274,146
R01 · FY2001 · AG
MOLECULAR ANALYSIS OF APOPTOSIS IN T CELLS$266,390
R01 · FY2000 · AG